LWCFA
GMED icon

Loring Wolcott & Coolidge Fiduciary Advisors’s Globus Medical GMED Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25
Closed -$2K – 828
2021
Q2 		$2K Buy
+25
New +$1.78K ﹤0.01% 858

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's GMED Position: Q3 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Globus Medical (GMED) in Q3 2021, closing a stake of 25 shares — an estimated $2K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GMED in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 388 funds tracked by Wall St. Rank hold GMED as of Q3 2021.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Globus Medical position as of Q3 2021 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 25 Globus Medical shares in Q3 2021, an estimated $2K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Globus Medical in Q2 2021 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Globus Medical position peaked at $2K in Q2 2021.
  • 388 funds tracked by Wall St. Rank held Globus Medical as of Q3 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.